Product Images Sirolimus
View Photos of Packaging, Labels & Appearance
Product Label Images
The following 12 images provide visual information about the product associated with Sirolimus NDC 66689-347 by Vistapharm, Llc, such as packaging, labeling, and the appearance of the drug itself. This resource could be helpful for medical professionals, pharmacists, and patients seeking to verify medication information and ensure they have the correct product.
structure - sirolimus oral solution 1
Container Label - sirolimus oral solution 10
This is an oral solution of Sirolimus packaged in a 60mL container with NDC code 66689-347-02. Each milliliter of the solution contains 1mg of Sirolimus along with additional compounds such as ethanol, fosphaldyiholne, and polysorbate 80. The usual dosage information is available in the package insert. The solution must be refrigerated and protected from light. It has to be consumed within a month of opening the container. This product is for oral use only and must be kept out of reach of children. The manufacturer is Novitium Pharma LLC and the product is distributed by VistaPharm, Inc.*
Carton-Label - sirolimus oral solution 11
This is a medication description for Sirolimus Oral Solution manufactured by "Rovtum Pramaiic". The recommended usage and storage information of the medication is provided. It is advised to use the contents within 1 month after opening the package and keep it away from children's reach. The medication is for oral use only and should be protected from light. The manufacturer's contact information is also mentioned.*
Patient-Kit - sirolimus oral solution 12
Sirolimus Oral Solution is a medication indicated to prevent rejection of kidney transplants in adults. The package insert contains instructions for use. Each mL contains 1.0 mg of sirolimus. The recommended dosage depends on the patient's body weight, clinical situation, and concomitant immunosuppressive therapy. It should be used orally only, and the quantity administered should be measured using a calibrated syringe. The medication must be kept out of reach of children and stored in a cool, dark place. If the solution turns cloudy, it should not be used. Individual syringes should be discarded after opening, and the contents of the bottle should be used within one month. If ingested in very high doses, the medication can be harmful to individuals with liver disease, pregnant women, and their fetuses.*
Figure - sirolimus oral solution 2
Figure-1 - sirolimus oral solution 3
Not available.*
Figure-2 - sirolimus oral solution 4
Figure-3 - sirolimus oral solution 5
Figure-4 - sirolimus oral solution 6
Figure-5 - sirolimus oral solution 7
Figure-6 - sirolimus oral solution 8
Figure-7 - sirolimus oral solution 9
This text is a description of Figure 7 showing how a syringe is being emptied into a glass.*
* The product label images have been analyzed using a combination of traditional computing and machine learning techniques. It should be noted that the descriptions provided may not be entirely accurate as they are experimental in nature. Use the information in this page at your own discretion and risk.